11/02/2022
In July 2022 the CDC responded to the presentation of the clinical trials of Doxy-PEP. STI's are on the Rise in the US. Data presented at the 2022 International AIDS Conference showed a significant effectiveness of the Dox-PEP protocol to reduce acquisition of syphilis and chlamydia in the gay, bis*xual and transgender women populations.
"We must move quickly to implement powerful STI prevention strategies. And it is our public health imperative to develop responsible guidance, based on a careful consideration of all available data and public health risks and benefits – we cannot take short cuts when it comes to people’s health.
In the coming months, CDC in collaboration with trial investigators and other partners, will be reviewing the data, both to develop interim clinical guidance, as well as to outline key additional research questions moving forward."
Though the cdc would not sanction complete approval, the did give support to at risk they did individuals and healthcare providers within the community of Men how have s*x with men. Doxy-PEP may be a powerful tool which should be taken under considerations to those at risk populations.
Someone has to take the step, so we at DDCHealth did just that. We are offering the Protocol to any of our patients who are at risk and meet the guidelines at a reduced cost.. The initial offering will be at reduced for all patients who Start the Protocol. This offer won't last long so get your consultation today! Go to
DDCHealth: Men's Health clinic that caters to Men Who have S*x with Men. We assess and treat erectile dysfunction, s*xual transmitted infection and low testosterone.
